To kick things off, we'll set the stage on what defines non-muscle invasive bladder cancer and how we triage patient ...

A novel drug-delivery system has demonstrated effectiveness in treating specific bladder cancer patients whose tumors ...

The PIVOT-006 trial is part of a larger national effort to evaluate cretostimogene’s safety and effectiveness in bladder ...

The National Institute for Health and Care Excellence (NICE) published draft guidance recommending avelumab (Bavencio, Merck Serono) for the treatment of certain forms of bladder cancer. Adults with ...

A breakthrough in bladder cancer treatment is helping save more lives. The American Cancer Society estimates that 83,000 new cases of bladder cancer will be diagnosed this year. 17,000 will die from ...

A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with high-risk non-muscle-invasive bladder cancer whose cancer had previously ...

Discover a study exploring how bladder cancer organoids advance personalised drug testing, reveal tumour heterogeneity, and ...

Bladder cancer treatment continues to evolve with a growing emphasis on balancing oncological efficacy and quality of life. Traditional approaches such as radical cystectomy, which involves removal of ...

NEW HAVEN, Conn. (WTNH) — The FDA recently approved the first breakthrough treatment for bladder cancer in 40 years. It comes at a time when Coach Prime – Deion Sanders – is sharing his bladder cancer ...

A groundbreaking targeted treatment for the most common type of bladder cancer has been approved for use by the NHS, offering new hope to hundreds of patients. The National Institute of Health and ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...